Unaudited Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities
Net income (loss)	$ 5,266,277	$ (3,093,143)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Accretion of asset retirement obligations	123,468	101,277
Depreciation and amortization	2,437,500	156,127
Amortization of debt issuance costs	48,375
Equity-based compensation	550,805	2,145,333
Deferred income tax expense	708,465
Changes in operating assets and liabilities:
Accounts receivable	(16,330,602)	(659,458)
Prepaid expenses	(1,463,598)	(686,905)
Inventories	(73,632)	(651,669)
Other assets	44,123	7,641
Accounts payable	8,561,670	(4,632,988)
Accrued expenses	(3,563,510)	(1,119,581)
Net cash from operating activities	3,436,361	(6,194,204)
Cash flow from investing activities:
Purchases of property, plant and equipment	(12,768,964)	(11,447,432)
Purchase of investment securities		(14,913,824)
Proceeds from maturities of investment securities	5,199,861	10,499,000
Net cash from investing activities	(7,569,103)	(15,862,256)
Cash flows from financing activities
Proceeds from issuance of common stock		47,709,000
Payments of equity offering costs		(1,755,685)
Repayments to Ramaco Coal, LLC		(10,629,275)
Repayments of financed insurance payable	(220,290)	(91,224)
Proceeds from notes payable, net	6,000,000
Payment of debt issuance costs	(257,440)
Payment of note payable		(500,000)
Payment of distributions		(3,905,224)
Net cash from financing activities	5,522,270	30,827,592
Net change in cash and cash equivalents	1,389,528	8,771,132
Cash and cash equivalents, beginning of period	5,934,043	5,196,914
Cash and cash equivalents, end of period	7,323,571	13,968,046
Supplemental cash flow information:
Cash paid for interest	56,881	81,091
Cash paid for taxes
Non-cash investing and financing activities:
Capital expenditures included in accounts payable and accrued liabilities	3,171,833	5,794,278
Financed insurance	788,921
Additional asset retirement obligations acquired or incurred	88,417	193,216
Accretion – Series A preferred units		$ 123,825